8,843
Views
26
CrossRef citations to date
0
Altmetric
Adopting More Holistic Approaches

Treatment Choice With Trial Data: Statistical Decision Theory Should Supplant Hypothesis Testing

Pages 296-304 | Received 06 Dec 2017, Accepted 08 Aug 2018, Published online: 20 Mar 2019

References

  • Berger, J. (1985), Statistical Decision Theory and Bayesian Analysis (2nd ed.), New York: Springer.
  • Berger, J. (2006), “The Case for Objective Bayesian Analysis,” Bayesian Analysis, 1, 385–402. DOI: 10.1214/06-BA115.
  • Canner, P. (1970), “Selecting One of Two Treatments When the Responses Are Dichotomous,” Journal of the American Statistical Association, 65, 293–306. DOI: 10.1080/01621459.1970.10481080.
  • Cheng, Y., Su, F., and Berry, D. (2003), “Choosing Sample Size for a Clinical Trial Using Decision Analysis,” Biometrika, 90, 923–936. DOI: 10.1093/biomet/90.4.923.
  • DeGroot, M. (1970), Optimal Statistical Decisions, New York: McGraw-Hill.
  • Dominitz, J., and Manski, C. (2017), “More Data or Better Data? A Statistical Decision Problem,” Review of Economic Studies, 84, 1583–1605.
  • Ferguson, T. (1967), Mathematical Statistics: A Decision Theoretic Approach, San Diego, CA: Academic Press.
  • Fisher, L., and Moyé, L. (1999), “Carvedilol and the Food and Drug Administration Approval Process: An Introduction,” Controlled Clinical Trials, 20, 1–15. DOI: 10.1016/S0197-2456(98)00052-X.
  • Fleiss, J. (1973), Statistical Methods for Rates and Proportions, New York: Wiley.
  • Garthwaite, P., Kadane, J., and O’Hagan, A. (2005), “Statistical Methods for Eliciting Probability Distributions,” Journal of the American Statistical Association, 100, 680–701. DOI: 10.1198/016214505000000105.
  • Higgings, J., and Green, S. (eds.) (2011), Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0, The Cochrane Collaboration, available at http://handbook-5-1.cochrane.org.
  • Hirano, K., and Porter, J. (2009), “Asymptotics for Statistical Treatment Rules,” Econometrica, 77, 1683–1701.
  • Hodges, E., and Lehmann, E. (1950), “Some Problems in Minimax Point Estimation,” Annals of Mathematical Statistics, 21, 182–197. DOI: 10.1214/aoms/1177729838.
  • International Conference on Harmonisation, ICH E9 Expert Working Group (1999), “Statistical Principles for Clinical Trials: ICH Harmonized Tripartite Guideline,” Statistics in Medicine, 18, 1905–1942.
  • Ioannidis, J. (2005), “Why Most Published Research Findings Are False,” PLoS Medicine, 2, 696–701.
  • Karlin, S., and Rubin, H. (1956), “The Theory of Decision Procedures for Distributions with Monotone Likelihood Ratio,” Annals of Mathematical Statistics, 27, 272–299. DOI: 10.1214/aoms/1177728259.
  • Kitagawa, T. and Tetenov, A. (2018), “Who Should be Treated? Empirical Welfare Maximization Methods for Treatment Choice,” Econometrica, 86, 591–616. DOI: 10.3982/ECTA13288.
  • Koriat, A., Lichtenstein, S., and Fischhoff, B. (1980), “Reasons for Confidence,” Journal of Experimental Psychology: Human Learning and Memory, 6, 107–118. DOI: 10.1037//0278-7393.6.2.107.
  • Manski, C. (2003), Partial Identification of Probability Distributions, New York: Springer.
  • Manski, C. (2004a), “Statistical Treatment Rules for Heterogeneous Populations,” Econometrica, 72, 221–246.
  • Manski, C. (2004b), “Measuring Expectations,” Econometrica, 72, 1329–1376.
  • Manski, C. (2005), Social Choice With Partial Knowledge of Treatment Response, Princeton, NJ: Princeton University Press.
  • Manski, C. (2007a), Identification for Prediction and Decision, Cambridge, MA: Harvard University Press.
  • Manski, C. (2007b), “Minimax-Regret Treatment Choice With Missing Outcome Data,” Journal of Econometrics, 139, 105–115.
  • Manski, C., and Tetenov, A. (2016), “Sufficient Trial Size to Inform Clinical Practice,” Proceedings of the National Academy of Sciences, 113, 10518–10523. DOI: 10.1073/pnas.1612174113.
  • Morgan, G. and Henrion, M. (1990), Uncertainty: A Guide to Dealing With Uncertainty in Quantitative Risk and Policy Analysis, New York: Cambridge University Press.
  • Parmigiani, G. and Inoue, L. (2009), Decision Theory: Principles and Approaches, New York: Wiley.
  • Savage, L. (1951), “The Theory of Statistical Decision,” Journal of the American Statistical Association, 46, 55–67. DOI: 10.1080/01621459.1951.10500768.
  • Savage, L. (1971), “Elicitation of Personal Probabilities and Expectations,” Journal of the American Statistical Association, 66, 783–801. DOI: 10.1080/01621459.1971.10482346.
  • Schlag, K. (2006), “Eleven Tests Needed for a Recommendation,” European University Institute Working Paper ECO No. 2006/2.
  • Spiegelhalter, D., Freedman, L., and Parmar, M. (1994), “Bayesian Approaches to Randomized Trials” (with discussion), Journal of the Royal Statistics Society, Series A, 157, 357–416. DOI: 10.2307/2983527.
  • Spiegelhalter, D. (2004), “Incorporating Bayesian Ideas Into Health-Care Evaluation,” Statistical Science, 19, 156–174. DOI: 10.1214/088342304000000080.
  • Stoye, J. (2009), “Minimax Regret Treatment Choice With Finite Samples,” Journal of Econometrics, 151, 70–81. DOI: 10.1016/j.jeconom.2009.02.013.
  • Stoye, J. (2012), “Minimax Regret Treatment Choice With Covariates or With Limited Validity of Experiments,” Journal of Econometrics, 166, 138–156.
  • Tetenov, A. (2012), “Statistical Treatment Choice Based on Asymmetric Minimax Regret Criteria,” Journal of Econometrics, 166, 157–165. DOI: 10.1016/j.jeconom.2011.06.013.
  • U.S. Food and Drug Administration (2010), Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials. Available at https://www.fda.gov/MedicalDevices/ucm071072.htm.
  • Wald, A. (1950), Statistical Decision Functions, New York: Wiley.
  • Wasserstein, R., and Lazar, N. (2016), “The ASA’s Statement on p-Values: Context, Process, and Purpose,” The American Statistician, 70, 129–133. DOI: 10.1080/00031305.2016.1154108.